{"podcast":{"title":"Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology","slug":"weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980","podcast_index_feed_id":7345980,"rss_url":"https://anchor.fm/s/ff5a3958/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/amer-ghavanini","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/42741030/42741030-1735440401368-ad7d63bca66f6.jpg","author":"Amer Ghavanini","episode_count":207,"summary":"A selection of recent neurology papers is summarized and discussed, with a focus on review articles and those that have the potential to change clinical practice. Please note that AI has been used in generating the content.","last_synced_at":"2026-07-07T06:17:21.772797+00:00","page_url":"https://stenobird.com/podcast/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980"},"episode":{"title":"Identifying Autoimmune Encephalitis in Rapidly Progressive Dementia","slug":"identifying-autoimmune-encephalitis-in-rapidly-progressive-dementia","published_at":"2026-05-24T12:17:05+00:00","page_url":"https://stenobird.com/podcast/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980/identifying-autoimmune-encephalitis-in-rapidly-progressive-dementia","show_page_url":"https://stenobird.com/podcast/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980","url":"https://podcasters.spotify.com/pod/show/amer-ghavanini/episodes/Identifying-Autoimmune-Encephalitis-in-Rapidly-Progressive-Dementia-e3jqpol","audio_url":"https://anchor.fm/s/ff5a3958/podcast/play/120464597/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-24%2Fede6419f-5159-b1a6-1c3a-f3bd0cad4ace.m4a","summary":"This study examines the prevalence and clinical characteristics of autoimmune encephalitis (AE) as a significant, treatable cause of rapidly progressive dementia (RPD) . Research involving 147 patients revealed that AE is the most frequent reversible diagnosis within this category, often presenting with distinctive features like early-onset seizures and specific imaging abnormalities. Key identified subtypes include anti-LGI1 encephalitis and autoimmune GFAP astrocytopathy , the latter of which frequently manifests through psychiatric symptoms or movement disorders. The findings distinguish AE from non-responsive conditions like Creutzfeldt-Jakob disease , noting that while both can share similar biomarkers, AE symptoms typically emerge earlier and respond well to immunotherapy . Ultimately, the authors emphasize that proactive, comprehensive autoantibody testing in both serum and spinal fluid is essential for preventing diagnostic delays and improving patient outcomes.","meta_description":"This study examines the prevalence and clinical characteristics of autoimmune encephalitis (AE) as a significant, treatable cause of rapidly progressive d…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1138,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980/episodes/identifying-autoimmune-encephalitis-in-rapidly-progressive-dementia/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/weekly-neurology-deep-dive-a-review-of-recent-impactful-publications-in-the-field-of-neurology-7345980/identifying-autoimmune-encephalitis-in-rapidly-progressive-dementia.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}